SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $51,000 | -26.1% | 29,511 | -4.3% | 0.00% | -25.0% |
| Q2 2015 | $69,000 | +4.5% | 30,842 | -9.4% | 0.00% | 0.0% |
| Q1 2015 | $66,000 | +1.5% | 34,052 | +39.4% | 0.00% | 0.0% |
| Q4 2014 | $65,000 | -33.7% | 24,422 | -25.0% | 0.00% | -42.9% |
| Q3 2014 | $98,000 | -25.8% | 32,567 | +1.3% | 0.01% | -22.2% |
| Q2 2014 | $132,000 | -3.6% | 32,164 | +1.5% | 0.01% | -10.0% |
| Q1 2014 | $137,000 | -13.8% | 31,701 | +4.2% | 0.01% | -9.1% |
| Q4 2013 | $159,000 | – | 30,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
| Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
| CAXTON CORP | 57,000 | $99,000 | 0.13% |
| Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
| TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
| Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
| LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
| Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |